Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 20 Dec 2022 22:14 CET |
TARGOVAX | Targovax ASA issues options to employees | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 Dec 2022 07:00 CET |
TARGOVAX | Targovax starter samarbeid med Agenus for å teste TG som behandling mot bukspyttkjertelkreft | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 15 Dec 2022 07:00 CET |
TARGOVAX | Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Dec 2022 11:49 CET |
TARGOVAX | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Dec 2022 11:49 CET |
TARGOVAX | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 07 Dec 2022 07:00 CET |
TARGOVAX | Targovax to present and attend at upcoming conferences | 20103010 Biotechnology | Non-regulatory press releases |
| 10 Nov 2022 07:00 CET |
TARGOVAX | Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from Targovax ASA in asset purchase agreement | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Nov 2022 07:00 CET |
TARGOVAX | Targovax ASA: Third quarter 2022 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 26 Oct 2022 07:00 CEST |
TARGOVAX | Invitation to Targovax's third quarter 2022 presentation, Thursday 3 November | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Oct 2022 08:20 CEST |
TARGOVAX | The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research - with updated publication info | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Oct 2022 07:00 CEST |
TARGOVAX | The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research | 20103010 Biotechnology | Non-regulatory press releases |
| 05 Oct 2022 14:05 CEST |
TARGOVAX | The ONCOS-102 phase 1b melanoma study selected for oral presentation at the SITC 2022 annual meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Sep 2022 07:00 CEST |
TARGOVAX | Targovax receives approval to proceed with the ONCOS-102 phase 2 melanoma study from the US FDA | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Sep 2022 07:00 CEST |
TARGOVAX | Targovax' studie i føflekkreft har blitt godkjent for oppstart av amerikanske FDA | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 26 Sep 2022 14:00 CEST |
TARGOVAX | Reminder: Targovax to host Investor Event 27 September | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Sep 2022 14:00 CEST |
TARGOVAX | Påminnelse: Targovax arrangerer investormøte 27. september | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 19 Sep 2022 11:54 CEST |
TARGOVAX | Targovax arrangerer investormøte: Møt ledelsen 27. september | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 19 Sep 2022 11:54 CEST |
TARGOVAX | Targovax to host Investor Event: Meet the Management on 27 September | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Sep 2022 07:00 CEST |
TARGOVAX | Targovax to present at upcoming conferences | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Aug 2022 07:00 CEST |
TARGOVAX | Targovax ASA: Second quarter and first half year 2022 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 11 Aug 2022 07:00 CEST |
TARGOVAX | Targovax ASA: Invitation to Targovax's second quarter and first half 2022 presentation, Thursday 18 August | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Jul 2022 16:49 CEST |
TARGOVAX | Notification of changed shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Jul 2022 09:45 CEST |
TARGOVAX | Targovax: Completion of drop-down demerger | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jun 2022 07:00 CEST |
TARGOVAX | Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA | 20103010 Biotechnology | Non-regulatory press releases |
| 23 Jun 2022 07:00 CEST |
TARGOVAX | Targovax: FDA gir tillatelse til å starte kliniske studier med ny og forbedret TG01 kreftvaksine i USA | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 07 Jun 2022 15:45 CEST |
TARGOVAX | Targovax ASA: Registration of share capital increase following settlement of restricted stock units and exercise of employee options | 20103010 Biotechnology | Total number of voting rights and capital |
| 31 May 2022 23:19 CEST |
TARGOVAX | Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 31 May 2022 14:17 CEST |
TARGOVAX | Targovax ASA: Exercise of options, settlement of restricted stock units and resolutions to increase the share capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 May 2022 07:00 CEST |
TARGOVAX | Targovax announces publication of the two abstracts accepted for poster presentation at ASCO 2022 | 20103010 Biotechnology | Non-regulatory press releases |
| 12 May 2022 07:00 CEST |
TARGOVAX | Targovax ASA: First quarter 2022 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 11 May 2022 15:34 CEST |
TARGOVAX | Targovax announces clinical collaboration with Agenus for upcoming ONCOS-102 phase 2 melanoma trial | 20103010 Biotechnology | Inside information |
| 11 May 2022 07:00 CEST |
TARGOVAX | Targovax to present at upcoming conferences | 20103010 Biotechnology | Non-regulatory press releases |
| 10 May 2022 08:11 CEST |
TARGOVAX | Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma | 20103010 Biotechnology | Non-regulatory press releases |
| 03 May 2022 07:00 CEST |
TARGOVAX | Targovax ASA: Invitation to presentation of Targovax's first quarter 2022 results, Thursday 12 May | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Apr 2022 07:00 CEST |
TARGOVAX | Targovax ASA: Two ONCOS-102 abstracts accepted for ASCO | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Apr 2022 07:00 CEST |
TARGOVAX | Targovax to present at 5th Neoantigen Summit Europe in Amsterdam | 20103010 Biotechnology | Non-regulatory press releases |
| 21 Apr 2022 07:00 CEST |
TARGOVAX | Targovax ASA announces the appointment of two new Board Directors | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Apr 2022 22:50 CEST |
TARGOVAX | Targovax ASA: Issuance of restricted stock units (RSUs) to the board members | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 14 Mar 2022 19:34 CET |
TARGOVAX | Targovax - Proposal to implement a drop-down demerger | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Mar 2022 14:41 CET |
TARGOVAX | Targovax ASA: Annual Report 2021 | 20103010 Biotechnology | Annual financial and audit Reports |
| 09 Mar 2022 07:00 CET |
TARGOVAX | Targovax ASA: Poster presentation at the AACR Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Mar 2022 10:31 CET |
TARGOVAX | Targovax ASA: Registration of share capital increases following exercise of options | 20103010 Biotechnology | Total number of voting rights and capital |
| 07 Mar 2022 22:41 CET |
TARGOVAX | Targovax ASA: GRANT OF SHARE OPTIONS TO NEW CFO | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 07 Mar 2022 13:00 CET |
TARGOVAX | Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULONT | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Mar 2022 10:05 CET |
TARGOVAX | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Mar 2022 23:15 CET |
TARGOVAX | Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 02 Mar 2022 23:06 CET |
TARGOVAX | Targovax ASA: Exercise of options under LTI program, settlement of RSUs and resolution to increase the share capital | 20103010 Biotechnology | Total number of voting rights and capital |
| 28 Feb 2022 07:21 CET |
TARGOVAX | Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Feb 2022 07:00 CET |
TARGOVAX | Targovax ASA: Fourth quarter 2021 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 09 Feb 2022 07:00 CET |
TARGOVAX | Targovax ASA: Invitation to presentation of Targovax's fourth quarter 2021 results, Thursday 17 February | 20103010 Biotechnology | Non-regulatory press releases |